AGCO and CP Group will each own 50% of a manufacturing joint venture which will produce protein production solutions for AGCO’s GSI division and CPG companies. Manufacturing is expected to begin in early 2019 in a plant to be constructed in CiXi City, ZheJiang Province, China. “Our new manufacturing joint venture with CP Group will greatly expand GSI’s Asian production capabilities and allow us to provide technologically advanced solutions for CPG and other producers in China. The joint venture will support CP Group’s planned expansion in Asia while enabling AGCO to better serve other animal protein producers in the region,” said Martin Richenhagen, AGCO’s Chairman, President and Chief Executive Officer.
Safe Harbor Statement
Statements which are not historical facts, including expectations regarding this transaction are forward-looking and subject to risks that could cause actual results to differ materially from those suggested by the statements. These risks include possible declines in demand for products as a result of weather, demand and other conditions that impact farm income, actions by producers of competitive products, and the general risks attendant to acquisitions and joint ventures. AGCO disclaims any obligation to update any forward-looking statements except as required by law.
